Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms underlying linear ubiquitination and implications in tumorigenesis and drug discovery. | Cell Commun Signal | 2023 | 38017534 | PubTator, text mining | PubMed |
| Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus. | Medicina (Kaunas) | 2023 | 38004071 | PubTator, text mining | PubMed |
| The Anti-Oxidative, Anti-Inflammatory, Anti-Apoptotic, and Anti-Necroptotic Role of Zinc in COVID-19 and Sepsis. | Antioxidants (Basel) | 2023 | 38001795 | PubTator, text mining | PubMed |
| PSMC5 regulates microglial polarization and activation in LPS-induced cognitive deficits and motor impairments by interacting with TLR4. | J Neuroinflammation | 2023 | 38001534 | PubTator, text mining | PubMed |
| Toll-like receptor signalling via IRAK4 affects epithelial integrity and tightness through regulation of junctional tension. | Development | 2023 | 37997696 | PubTator, text mining | PubMed |
| Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts-A cross-sectional study. | PLOS Glob Public Health | 2023 | 37992019 | PubTator, text mining | PubMed |
| Metabolomics analysis of quality components metabolism during the growth process of pepino (Solanum muricatum) fruit. | Plant Signal Behav | 2023 | 37976083 | PubTator, text mining | PubMed |
| USP3 plays a critical role in the induction of innate immune tolerance. | EMBO Rep | 2023 | 37971847 | PubTator, text mining | PubMed |
| Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023). | World J Gastroenterol | 2023 | 37970478 | PubTator, text mining | PubMed |
| Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2023 | 37968706 | PubTator, text mining | PubMed |
| Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4. | Int J Mol Sci | 2023 | 37958859 | PubTator, text mining | PubMed |
| IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial. | Nat Med | 2023 | 37957373 | PubTator, text mining | PubMed |
| IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies. | Front Immunol | 2023 | 37954584 | PubTator, text mining | PubMed |
| New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review. | Infect Dis Ther | 2023 | 37938418 | PubTator, text mining | PubMed |
| The gut-lung axis in influenza A: the role of gut microbiota in immune balance. | Front Immunol | 2023 | 37928517 | PubTator, text mining | PubMed |
| Tolerogenic dendritic cells and TLR4/IRAK4/NF-κB signaling pathway in allergic rhinitis. | Front Immunol | 2023 | 37915574 | PubTator, text mining | PubMed |
| Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics. | Pharmaceutics | 2023 | 37896221 | PubTator, text mining | PubMed |
| TACkling Cancer by Targeting Selective Protein Degradation. | Pharmaceutics | 2023 | 37896202 | PubTator, text mining | PubMed |
| Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. | Int J Mol Sci | 2023 | 37894816 | PubTator, text mining | PubMed |
| Lupus Nephritis in Children: Novel Perspectives. | Medicina (Kaunas) | 2023 | 37893559 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=13